COMMUNIQUÉS West-GlobeNewswire

Retrophin to Present Long-Term Data from Phase 2 DUET Study of Sparsentan in FSGS at ASN Kidney Week 2018
05/10/2018
SAN DIEGO, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that it will present new data examining the long-term effects of sparsentan in focal segmental glomerulosclerosis (FSGS), at [...]
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05/10/2018
RADNOR, Pa., Oct. 05, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
Genetic Testing: Thinking About An At-Home Test for Alzheimer’s Risk Gene?
05/10/2018
What You Need to Know—First NEW YORK, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Persons wishing to learn their genetic risk for Alzheimer’s disease —by way of an at-home genetic test—should first consider consulting with their [...]
Sienna Announces Third Quarter 2018 Results Release Date and Conference Call
05/10/2018
MARKHAM, Ontario, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced that it will report its 2018 third quarter results after market close on Wednesday, [...]
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs, Raising Gross Proceeds of $345 Million and Full Exercise of Underwriters' Option to Purchase Additional ADSs
05/10/2018
LONDON and CARLSBAD, Calif., Oct. 05, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, "GW," and the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel [...]
Co-administration of AAV Vectors with SVP-Rapamycin Enables Vector Re-administration in Pre-clinical Gene Therapy Study Published in Nature Communications by Généthon and Selecta Biosciences
05/10/2018
Represents a potentially powerful strategy to modulate vector immunogenicity and may open new therapeutic avenues for AAV vector-mediated gene transfer EVRY, France and WATERTOWN, Mass., Oct. 05, 2018 (GLOBE NEWSWIRE [...]
About acquisition of significant shareholding
05/10/2018
On October 5, 2018, JSC Olainfarm has received a notification from shareholder Irina Maligina on increased material shareholding up till 7.79% from share capital with voting rights, since the 25 th of September, 2018. [...]
XBiotech annonce la conclusion du recrutement pour l'étude multicentrique de phase 2 d'évaluation de Bermekimab chez les patients atteints d'une dermatite atopique
05/10/2018
AUSTIN, Texas, 05 oct. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd'hui avoir terminé le recrutement pour son étude clinique ouverte de phase 2 consacrée à l'évaluation de l'administration [...]
KemPharm Announces Pricing of Public Offering of Common Stock
05/10/2018
CORALVILLE, Iowa, Oct. 05, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced the pricing of its [...]
Eidos Therapeutics to Present Phase 2 Data for AG10 in TTR Amyloidosis Cardiomyopathy at the AHA 2018 Scientific Sessions in a Late-Breaking Featured Science Oral Presentation
05/10/2018
SAN FRANCISCO, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), today announced that results of its Phase 2 clinical trial studying AG10 in subjects with symptomatic transthyretin (TTR) [...]
FSD Pharma Takes the Spotlight in CNBC's Cannabis Coverage -- CFN Media
05/10/2018
SEATTLE, Wash., Oct. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
Medibio Provides Updated Company Presentation
05/10/2018
SYDNEY, Australia and MINNEAPOLIS, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company )(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, is pleased to release an updated company [...]
Chemesis Rolling Up High Value Cannabis Assets in United States -- CFN Media
05/10/2018
SEATTLE, Oct. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
VPR Brands Showcasing its GOLDLINE Hemp Brand at NACS Expo in Las Vegas
05/10/2018
FORT LAUDERDALE, FL, Oct. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- VPR Brands, LP (OTC PINK: VPRB), a market leader specializing in accessories and vaporizers for essential oils, cannabis concentrates and [...]
Sarepta Announces Agreement with Nationwide Children’s Hospital for Rights to its Gene Therapy Program to Treat Charcot-Marie-Tooth (CMT) Neuropathy, Globally the Most Common Inherited Neuromuscular Disorder
05/10/2018
-- Furthers the Company’s strategy to expand neuromuscular gene therapy franchise -- -- CMT is a group of hereditary, degenerative nerve diseases that in addition to causing extraordinary pain, can greatly impact [...]
Agritek Holdings, Inc. Announces First Approved Hospitality Model And Full Service Wellness Resort As Cannabis Approaches Legalization In Canada This Month
05/10/2018
LOS ANGELES, CA, Oct. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the United [...]
Veritas Signs MOU with Leader in Puerto Rico’s Medicinal Cannabis Market
05/10/2018
VANCOUVER, B.C., Oct. 05, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce along with the Institute for Medical Cannabis (the [...]
Histogenics Corporation Announces Pricing of Public Offering of Common Stock and Warrants
05/10/2018
WALTHAM, Mass., Oct. 05, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies, today announced the pricing of an underwritten public [...]
Iterum Therapeutics Presents Data Highlighting Antibiotic Sulopenem at IDWeek 2018
05/10/2018
DUBLIN, Ireland and CHICAGO, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, will present [...]

Pages